Regulation of erythrocyte membrane protein gene expression

Current Opinion in Hematology

Volumn 10, Issue 2, 2003, Pages 115-122

  Gallagher, Patrick G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE BAND 4.1 PROTEIN; FODRIN; GENE PRODUCT; ISOPROTEIN; MEMBRANE PROTEIN; SPECTRIN BETA SUBUNIT; UNCLASSIFIED DRUG;

CELL TYPE; DEVELOPMENTAL STAGE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROID CELL; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; HEMATOPOIESIS; KIDNEY; PATHOGENESIS; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA SPLICING; SEQUENCE HOMOLOGY; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ERYTHROCYTE MEMBRANE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; PROTEIN ISOFORMS;

EID: 0037370756     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200303000-00003     Document Type: Review

References (84)

1. Morrow JS, Rimm DL, Kennedy SP, et al.: Of membrane stability and mosaics: the spectrin cytoskeleton. In Handbook of Physiology. Edited by Hoffman J, Jamieson J. London: Oxford University Press; 1997:485-540.
2. Lander ES, Linton LM, Birren B, et al.: Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921. •• This report describes a draft sequence of the human genome with initial analyses of the data that provide several interesting observations, including insights into alternate slicing.
3. Cosma MP: Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell 2002, 10:227-236.
4. Kadener S, Cramer P, Nogues G, et al.: Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J 2001, 20:5759-5768.
5. Maniatis T, Reed R: An extensive network of coupling among gene expression machines. Nature 2002, 416:499-506.
6. Roberts GC, Gooding C, Mak HY, et al.: Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res 1998, 26:5568-5572.
7. Woychik NA, Hampsey M: The RNA polymerase II machinery: structure illuminates function. Cell 2002, 108:453-463.
8. Auboeuf D, Honig A, Berget SM, et al.: Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002, 298:416-419. •• This article demonstrates that steroid hormones, acting through steroid-responsive promoters, can coordinate influence RNA processing and exon selection.
9. Cramer P, Pesce CG, Baralle FE, et al.: Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci U S A 1997, 94:11456-11460.
10. Cramer P, Caceres JF, Cazalla D, et al.: Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 1999, 4:251-258.
11. Tasic B, Nabholz CE, Baldwin KK, et al.: Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol Cell 2002, 10:21-33.
12. Wang X, Su H, Bradley A: Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model. Genes Dev 2002, 16:1890-1905. • These reports show that promoter choice influences alternate splicing of corresponding RNAs.
13. Sahr KE, Laurila P, Kotula L, et al.: The complete cDNA and polypeptide sequences of human erythroid alpha-spectrin. J Biol Chem 1990, 265:4434-4443.
14. Kotula L, Laury-Kleintop LD, Showe L, et al.: The exon-intron organization of the human erythrocyte alpha-spectrin gene. Genomics 1991, 9:131-140.
15. Wong EY, Nilson DG, Wong C, et al.: An alternatively spliced intron is required for high level erythroid-specific expression of the human α-spectrin gene in vivo. Blood 2001, 98:436a.
16. Prchal JT, Papayannopoulou T, Yoon SH: Patterns of spectrin transcripts in erythroid and non-erythroid cells. J Cell Physiol 1990, 144:287-294.
17. Wandersee NJ, Birkenmeier CS, Gifford EJ, et al.: Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the enythroid α-spectrin gene. Hematol J 2000, 1:235-242.
18. Boulanger L, Sabatino DE, Wong EY, et al.: Erythroid expression of the human alpha-spectrin gene promoter is mediated by GATA-1- and NF-E2-binding proteins. J Biol Chem 2002, 277:41563-41570. • This is the first description of a mammalian α-spectrin gene promoter.
19. Winkelmann JC, Costa FF, Linzie BL, et al.: Beta spectrin in human skeletal muscle: tissue-specific differential processing of 3′ beta spectrin pre-mRNA generates a beta spectrin isoform with a unique carboxyl terminus. J Biol Chem 1990, 265:20449-20454.
20. Pradhan D, Morrow J: The spectrin-ankyrin skeleton controls CD45 surface display and interleukin-2 production. Immunity 2002, 17:303. •• These studies show that β-spectrin and ankyrin influence T-cell function by controlling CD45 expression and interleukin-2 production.
21. Chu ZL, Wickrema A, Krantz SB, et al.: Erythroid-specific processing of human beta spectrin I pre-mRNA. Blood 1994, 84:1992-1999.
22. Chu ZL, Komatsu N, Winkelmann JC: Regulation of human β-spectrin I pre-mRNA processing by enythropoietin (EPO) correlates with EPO-stimulated changes in SR protein phosphorylation in UT-7/EPO cells. Blood 1995, 86:416a.
23. Cheever ML, Winkelmann JC: Erythroid-specific cleavage of human beta spectrin pre-nRNA. Blood 2002, 110:224a.
24. Liao EC, Paw BH, Peters LL, et al.: Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid beta-spectrin structure, and function in red cell morphogenesis and membrane stability. Development 2000, 127:5123-5132. • Cloning of the zebrafish β-spectrin gene provides novel evolutionary insight into the function of β-spectrin.
25. Gallagher PG, Sabatino DE, Romana M, et al.: A human beta-spectrin gene promoter directs high level expression in erythroid but not muscle or neural cells. J Biol Chem 1999, 274:6062-6073.
26. Wang L, Forget BG: A human beta-spectrin gene promoter directs the selective expression of a novel reporter gene in erythroid and megakaryocytic cells of transgenic mice. Blood 2002, 110:223a.
27. Mishra L, Cai T, Levine A, et al.: Identification of elf1, a beta-spectrin, in early mouse liver development. Int J Dev Biol 1998, 42:221-224. • See [29•].
28. Mishra L, Cai T, Yu P, et al.: Elf3 encodes a novel 200-kD beta-spectrin: role in liver development. Oncogene 1999, 18:353-364. • See [29•].
29. Tang Y, Katuri V, Iqbal S, et al.: ELF a beta-spectrin is a neuronal precursor cell marker in developing mammalian brain; structure and organization of the elf/beta-G spectrin gene. Oncogene 2002, 21:5255-5267. • These articles describe the large and complex combination of isoforms of the βII isoform of spectrin.
30. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 1993, 3:283-291.
31. Peters LL, Lux SE: Ankyrins: structure and function in normal cells and hereditary spherocytes. Semin Hematol 1993, 30:85-118.
32. Birkenmeier CS, White RA, Peters LL, et al.: Complex patterns of sequence variation and multiple 5′ and 3′ ends are found among transcripts of the erythroid ankyrin gene. J Biol Chem 1993, 268:9533-9540.
33. Gallagher PG, Tse WT, Scarpa AL, et al.: Structure and organization of the human ankyrin-1 gene: basis for complexity of pre-mRNA processing. J Biol Chem 1997, 272:19220-19228.
34. Hall TG, Bennett V: Regulatory domains of erythrocyte ankyrin. J Biol Chem 1987, 262:10537-10545.
35. Davis LH, Davis JQ, Bennett V: Ankyrin regulation: an alternatively spliced segment of the regulatory domain functions as an intramolecular modulator. J Biol Chem 1992, 267:18966-18972.
36. Zhou D, Birkenmeier CS, Williams MW, et al.: Small, membrane-bound, alternatively spliced forros of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J Cell Biol 1997, 136:621-631.
37. Birkenmeier CS, Sharp JJ, Gifford EJ, et al.: An alternative first exon in the distal end of the erythroid ankyrin gene leads to production of a small isoform containing an NH2-terminal membrane anchor. Genomics 1998, 50:79-88.
38. Gallagher PG, Forget BG: An alternate promoter directs expression of a truncated, muscle-specific isoform of the human ankyrin 1 gene. J Biol Chem 1998, 273:1339-1348.
39. Lambert S, Bennett V: Postmitotic expression of ankyrinR and beta R-spectrin in discrete neuronal populations of the rat brain. J Neurosci 1993, 13:3725-3735.
40. Gallagher PG, Romana M, Tse WT, et al.: The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter. Blood 2000, 96:1136-1143.
41. Sabatino DE, Wong C, Cline AP, et al.: A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. J Biol Chem 2000, 275:28549-28554.
42. Gallagher PG, Wong E, Wong C: A novel isoform of ankyrin 1 (Ank1) expressed in brain, heart and skeletal muscle is directed by an alternate promoter. Blood 1998, 92:300a.
43. Tanner MJ: Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 2002, 9:133-139.
44. Kollert-Jons A, Wagner S, Hubner S, et al.: Anion exchanger 1 in human kidney and oncocytoma differs from erythroid AE1 in its NH2 terminus. Am J Physiol 1993, 265:F813-F821.
45. Kudrycki KE, Shull GE: Rat kidney band 3 Cl-/HCO3-exchanger mRNA is transcribed from an alternative promoter. Am J Physiol 1993, 264: F540-F547.
46. Sahr KE, Taylor WM, Daniels BP, et al.: The structure and organization of the human erythroid anion exchanger (AE1) gene. Genomics 1994, 24:491-501.
47. Schofield AE, Martin PG, Spillett D, et al.: The structure of the human red blood cell anion exchanger (EPB3, AE1, band 3) gene. Blood 1994, 84:2000-2012.
48. Brosius FC III, Alper SL, Garcia AM, et al.: The major kidney band 3 gene transcript predicts an amino-terminal truncated band 3 polypeptide. J Biol Chem 1989, 264:7784-7787.
49. Sahr KE, Daniels BP, Hanspal M: Identification of the proximal erythroid promoter region of the mouse anion exchanger gene. Blood 1996, 88:4500-4509.
50. Richards SM, Jaconi ME, Vassort G, et al.: A spliced variant of AE1 gene encodes a truncated form of band 3 in heart: the predominant anion exchanger in ventricular myocytes. J Cell Sci 1999, 112:1519-1528.
51. Papageorgiou P, Shmukler BE, Stuart-Tilley AK, et al.: AE anion exchangers in atrial tumor cells. Am J Physiol Heart Circ Physiol 2001, 280:H937-H945.
52. Kopito RR, Andersson MA, Lodish HF: Multiple tissue-specific sites of transcriptional initiation of the mouse anion antiport gene in erythroid and renal cells. Proc Natl Acad Sci U S A 1987, 84:7149-7153.
53. Philipp S, Kneussel M, Konig J, et al.: Molecular analysis of regulation of gene expression of the human erythroid anion exchanger (AE) 1. FEBS Lett 1998, 438:315-320.
54. Sivasubramaniam M, Wong C, Sahr K, et al.: Expression of the murine band 3 gene (AE1) erythroid promoter in vitro is mediated by GATA-1 and BKLF. Blood 2002, 100:224a.
55. Kim HR, Kennedy BS, Engel JD: Two chicken erythrocyte band 3 mRNAs are generated by alternative transcriptional initiation and differential RNA splicing. Mol Cell Biol 1989, 9:5198-5206.
56. Cox KH, Adair-Kirk TL, Cox JV: Four variant chicken erythroid AE1 anion exchangers: role of the alternative N-terminal sequences in intracellular targeting in transfected human erythroleukemia cells. J Biol Chem 1995, 270:19752-19760.
57. Cox KH, Adair-Kirk TL, Cox JV: Variant chicken kidney AE1 anion exchanger transcripts are derived from a single promoter by alternative splicing. Gene 1996, 173:221-226.
58. Takakuwa Y: Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: structure and functions in erythrocytes and nonerythroid cells. Int J Hematol 2000, 72:298-309.
59. Hoover KB, Bryant PJ: The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 2000, 12:229-234.
60. Conboy J: The role of alternative pre-mRNA splicing in regulating the structure and function of skeletal protein 4.1. Proc Soc Exp Biol Med 1999, 220:73-78.
61. Hou VC, Conboy JG: Regulation of alternative pre-mRNA splicing during erythroid differentiation. Curr Opin Hematol 2001, 8:74-79.
62. Gascard P, Lee G, Coulombel L, et al.: Characterization of multiple isoforms of protein 4.1 R expressed during erythroid terminal differentiation. Blood 1998, 92:4404-4414.
63. Horne WC, Huang SC, Becker PS, et al.: Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin. Blood 1993, 82:2558-2563.
64. Discher DE, Winardi R, Schischmanoff PO, et al.: Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening. J Cell Biol 1995, 130:897-907.
65. Baklouti F, Huang SC, Tang TK, et al.: Asynchronous regulation of splicing events within protein 4.1 pre-mRNA during erythroid differentiation. Blood 1996, 87:3934-3941.
66. Kontrogianni-Konstantopoulos A, Huang SC, Benz EJ Jr: A nonerythroid isoform of protein 4.1 R interacts with components of the contractile apparatus in skeletal myofibers. Mol Biol Cell 2000, 11:3805-3817.
67. Gee SL, Aoyagi K, Lersch R, et al.: Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice. Blood 2000, 95:692-699.
68. Deguillien M, Huang SC, Moriniere M, et al.: Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood 2001, 98:3809-3816. • This report reveals that sequences in and around protein 4.1 exon 16 interact to determine the inclusion or exclusion of exon 16 during erythroid differentiation.
69. Huang SC, Liu ES, Cheng H, et al.: Comparative analysis of cis-elements regulation protein 4.1R exon 16 splicing in cells that predominantly include or exclude exon 16 in vivo. Blood 2002, 110:223a.
70. Hou VC, Lersch R, Gee SL, et al.: Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. EMBO J 2002, 21:6195-6204. Interaction of a splicing silencer element in exon 16 of the protein 4.1 gene with hnRNP A/B proteins A influences exon 16 splicing in erythroid differentiation.
71. Ponthier JL, Chen WC, Gee SL, et al.: Positive regulation of protein 4.1R exon 16 alternative splicing may be mediated by interaction of HRNbp with intronic enhancers. Blood 2002, 110:222a.
72. Chasis JA, Coulombel L, McGee S, et al.: Differential use of protein 4.1 translation initiation sites during erythropoiesis: implications for a mutation-induced stage-specific deficiency of protein 4.1 during erythroid development. Blood 1996, 87:5324-5331.
73. Chasis JA, Coulombel L, Conboy J, et al.: Differentiation-associated switches in protein 4.1 expression: synthesis of multiple structural isoforms during normal human erythropoiesis. J Clin Invest 1993, 91:329-338.
74. Conboy J: Abundance of alternative first exons among genes encoding membrane skeletal proteins suggests an important role in regulating, expression. Blood 2002, 110:79a.
75. Tse WT, Lux SE: Red blood cell membrane disorders. Br J Haematol 1999, 104:2-13.
76. Gallagher PG, Sabatino DE, Basseres DS, et al.: Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression. J Biol Chem 2001, 276:41683-41689. Sequence variations identified in the ankyrin gene promoters of ankyrin-deficient spherocytosis patients have significant effects on promoter function in a transgenic mouse model.
77. Gallagher PG, Nilson DM, Wong C, et al.: A two base pair deletion at position -72/-73 of the ankyrin-1 promoter associated with hereditary spherocytosis disrupts TFIID complex binding and decreases transcription of a linked reporter gene. Blood 2002, 100:77a.
78. Weisbein JL, Wong C, Cline AP, et al.: Mutations at positions - 108 and - 153 of the erythroid ankyrin promoter decrease expression in transgenio mice by disrupting insulator function. Blood 2002, 110:78a.
79. Aγ-globin promoter prevents silencing of a linked human β-globin gene in transgenic mice. Mol Cell Biol 1998, 18:6634-6640.
80. Persons DA, Allay ER, Sabatino DE, et al.: Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Blood 2001, 97:3275-3282.
81. Dooner GJ, Barker JE, Gallagher PG, et al.: Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro. Exp Hematol 2000, 28:765-774.
82. Sabatino DE, Seidel NE, Aviles-Mendoza GJ, et al.: Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter. Proc Natl Acad Sci U S A 2000, 97:13294-13299.
83. Moreau-Gaudry F, Xia P, Jiang G, et al.: High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 2001, 98:2664-2672.
84. Persons DA, Hargrove PW, Allay ER, et al.: The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number. Blood 2002, in press.